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Chemotherapy Targets the Hair-Follicle Vascular
Network but Not the Stem Cells
Yasuyuki Amoh1,2,3, Lingna Li1, Kensei Katsuoka2 and Robert M. Hoffman1,3
Chemotherapy-induced alopecia is a major problem in clinical oncology. Doxorubicin, a widely used cancer
chemotherapy drug, induces disruption of the hair cycle and subsequent alopecia. We show in this report that
doxorubicin causes disruption of the hair-follicle-associated blood vessel network resulting in a greatly reduced
density of these blood vessels. Dystrophic hair follicles were also observed with abnormal melanogenesis in the
mice treated with doxorubicin. Visualization of the effect of doxorubicin on hair-follicle angiogenesis was made
possible by the use of transgenic mice in which green fluorescent protein was driven by regulatory elements of
the nestin gene (ND-GFP). In these transgenic mice, the hair-follicle stem cells and the follicle structure as well
as the blood vessels associated with the hair follicles express ND-GFP. The hair-follicle stem cells did not appear
to be affected by doxorubicin, which may explain why hair regrows after chemotherapy. These results suggest
that inhibition of hair-follicle-associated angiogenesis by doxorubicin may be an important factor in hair-follicle
dystrophy associated with chemotherapy-induced alopecia. The ND-GFP mouse model is thus useful for the
study of the role of angiogenesis in the hair-follicle cycle and the effect of drugs on processes associated with
chemotherapy-induced alopecia.
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INTRODUCTION
Chemotherapy can induce anagen hair follicles to develop
abnormalities that are termed hair-follicle dystrophy (Hendrix
et al., 2005). In some cases, chemotherapy induces the
‘‘dystrophic anagen’’ response pathway, a prolonged dys-
trophic anagen, followed by severely retarded follicular
recovery. Severe follicular damage induces the dystrophic
catagen pathway, and immediate anagen termination,
followed by a dystrophic, abnormally shortened telogen
and rapid follicular recovery. The C57BL/6J mouse model of
cyclophosphamide-induced alopecia was used to define
classification criteria for hair-follicle dystrophy including
structure and pigmentation of the hair shaft, location, and
volume of ectopic melanin granules, distension of the
follicular canal, number of TUNEL-labeled keratinocytes in
the hair bulb, and neural cell-adhesion molecule immuno-
reactivity (Hendrix et al., 2005).
The hair-follicle stem cells appear to reside in the
permanent upper portion of the hair follicle, the so-called
bulge area (Cotsarelis et al., 1990; Hoffman, 2000; Taylor
et al., 2000; Oshima et al., 2001). We have recently reported
(Li et al., 2003; Amoh et al., 2004, 2005a, b) that nestin, a
marker for neural progenitor cells (Lendahl et al., 1990;
Zimmerman et al., 1994; Yaworsky and Kappen, 1999), is
also selectively expressed in cells of the hair-follicle bulge.
Follicle bulge cells, labeled with nestin-driven green fluor-
escent protein (ND-GFP) in transgenic mice, behave as hair-
follicle stem cells, differentiating to form much of the hair
follicle during each hair growth cycle. We subsequently
reported that many of the newly formed nestin-expressing
blood vessels in the skin originate from the hair follicle,
presumably the hair-follicle stem cells during the anagen
phase (Amoh et al., 2004). These blood vessels are labeled in
transgenic mice by ND-GFP. The follicular origin of the ND-
GFP-expressing vessels is most evident when transplanting
ND-GFP-labeled follicles to unlabeled nude mice. After
transplantation, fluorescent new blood vessels originate only
from the labeled follicles. The vessels from the transplanted
ND-GFP follicles responded to presumptive angiogenic
signals from healing wounds. The ND-GFP-expressing blood
vessels display the characteristic endothelial cell-specific
markers CD31 and von Willebrand factor (Amoh et al.,
2004).
Using the ND-GFP mouse to image the hair-follicle stem
cells and associated blood vessels, we demonstrate in this
report that doxorubicin, a widely used cancer chemotherapy
agent, causes inhibition of the ND-GFP-expressing vessels
and dystrophy of the hair follicles. The hair-follicle stem cells
appear not to be affected by doxorubicin. These studies
suggest an important role of hair-follicle-associated blood
vessels in maintaining normal hair-follicle structure and
function and in chemotherapy-induced alopecia.
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RESULTS
Visualization of angiogenesis associated with hair-follicle
cycling in ND-GFP-transgenic mice
Before depilation (telogen), the ND-GFP-expressing cells
were located in the follicular bulge area and blood vessel
network. The blood vessel network interconnected hair
follicles via their bulge area (Figure 1b). At day 6 post-
depilation (p.d.) (middle anagen), ND-GFP-expressing outer-
root sheath cells were growing from ND-GFP-expressing cells
located in the follicular bulge area. The ND-GFP-expressing
nascent blood vessel network became more extensive in the
lower part of the hair follicular bulge area (Figure 1c). At day
12 p.d. (late anagen), the ND-GFP-expressing cells were
located in the follicular bulge area, outer-root sheath, and
hair-follicle blood vessel network (Figure 1d). At day 18 p.d.
(catagen), the ND-GFP-expressing cells were located in the
follicular bulge area, outer-root sheath, and blood vessel
network. The ND-GFP-expressing outer-root sheath cells
were undergoing regression and degeneration, and the ND-
GFP-expressing blood vessel network diminished (Figure 1e).
Immunohistochemical staining showed that CD31 and GFP
fluorescence colocalized in the ND-GFP-expressing blood
vessels (Figure 2).
The ND-GFP-expressing blood vessel total length in the
lower part of hair-follicle bulge was significantly longer at
day 6, 12, and 18 p.d. (middle and late anagen, and catagen)
than in telogen. The ND-GFP-expressing blood vessel length
in the upper part of the hair-follicle bulge in anagen and
catagen phase was comparable to that in telogen.
The growth of blood vessels in the lower part of the
hair-follicle bulge following/during anagen was significant
compared to telogen (P40.001) (Figure 3).
Doxorubicin causes inhibition of hair-follicle-associated blood
vessel growth
Dystrophic hair follicles and melanin clumps in the mice
treated with doxorubicin were noted in fresh tissue samples
by day 7 p.d. (Figure 4a and b). Weak ND-GFP fluorescence
was observed in the outer-root sheath (Figure 4c–e). By day
12, dystrophic hair follicles and melanin clumps appeared
and ND-GFP fluorescence was no longer observed in the
outer-root sheath. Furthermore, the number of ND-GFP-
expressing blood vessels in the mice treated with doxorubicin
was less than the control mice (Figure 5a and b). Similar
observations were made in frozen sections. In contrast, the
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Figure 1. Time course of hair-follicle blood vessel network development during the hair cycle. (a) Schematic of dorsal skin hair follicles showing the location
of ND-GFP-expressing cells at each stage of the hair-growth cycle. (b–e) The dorsal skin samples were directly observed by fluorescence microscopy with
epidermis up and dermis down in ND-GFP-transgenic mice at each stage of the hair-growth cycle. White arrowheads, white dashed areas: ND-GFP-expressing
hair follicular bulge area. Red arrowheads: ND-GFP-expressing blood vessels. Yellow arrowheads: ND-GFP-expressing outer-root sheath. The ND-GFP-
expressing blood vessel network (red arrowheads) interconnected with the hair follicular bulge area (white arrowheads, white dashed areas). (b) Note: the
hair shafts often displayed auto-fluorescence (asterisk). Bar¼ 100mm.
Vessel density in the
upper part of follicle (mm/mm2)
Vessel density in the
lower part of follicle (mm/mm2)
Day 0 (0.6870.08) Day 0 (0.4870.05)
Day 3 (0.6670.14) Day 3 (0.5170.06)
Day 6 (0.7870.15) Day 6 (0.8370.11)
Day 12 (0.5870.09) Day 12 (1.1670.17)
Day 18 (0.5570.08 ) Day 18 (0.6970.07)
Day 30 (0.7270.1) Day 30 (0.5770.11)
The data represent the mean values7SD.
12 Journal of Investigative Dermatology (2007), Volume 127
Y Amoh et al.
Chemotherapy and Hair-Follicle Vascular Network
hair follicle stem cells appeared not to be affected by
doxorubicin.
The ND-GFP-expressing blood vessel total length in the
lower part of hair-follicle bulge was significantly shorter in
the mice treated with doxorubicin than in the control mice
treated with NaCl. The ND-GFP-expressing blood vessel
length in the upper part of hair-follicle bulge in the mice
treated with doxorubicin was comparable to the control mice
treated with NaCl. The ND-GFP-expressing blood vessel
density in the upper part of the hair-follicle bulge area in
doxorubicin-treated mice was 0.59 (70.15) and in NaCl-
treated mice 0.58 (70.09). The ND-GFP-expressing blood
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Figure 3. ND-GFP-expressing blood vessel density during the hair cycle. The
skin samples were excised from dorsal skin before depilation (telogen) and at
day 3 (early anagen), day 6 (middle anagen), day 12 (late anagen), day 18
(catagen), and day 30 (telogen) p.d. The frozen skin sections were used for
measuring the length of ND-GFP-expressing blood vessels. At least five fields
were examined for each section, derived from three differential mice per hair
cycle stage. The data represent the mean values7SD. *Po0.001, significant
compared with the results obtained before depilation (telogen).
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Figure 4. Effect of doxorubicin on the hair follicle and hair-follicle blood
vessel network. (a and b) Dorsal skin samples were directly observed by light
microscopy with epidermis up and dermis down in ND-GFP-transgenic
mice. (a) At day 7 p.d., note the dystrophic hair follicles and the melanin
clumps in the mice treated with doxorubicin. (b) Hair follicles in the control
mice. Note the normal structure of the hair follicles. The dorsal skin samples
were directly observed by fluorescence microscopy with epidermis up and
dermis down in ND-GFP-transgenic mice. (c and d) At day 7 p.d., note the
weak ND-GFP fluorescence in the outer-root sheath (yellow arrowheads) and
the unaffected ND-GFP-expressing stem cells in the hair-follicle bulge area
(white arrowheads, white dashed areas). Note the dystrophic hair follicle and
the melanin clumps (blue arrowheads) in the mice treated with doxorubicin.
(e) Normal hair follicle fluorescence, from control mice. Note the normal
structure of the hair follicles, the ND-GFP-expressing stem cells in the
hair-follicle bulge area (white arrowheads, white dashed areas), the
ND-GFP-expressing outer-root sheath (yellow arrowheads), and
ND-GFP-expressing blood vessels (red arrowheads). Bar¼ 100mm.
a b
Figure 5. Dystrophic hair follicles and melanin clumping in doxorubicin-
treated mice. The dorsal skin samples from ND-GFP transgenic mice were
directly observed by fluorescence microscopy with epidermis up and dermis
down. (a) At day 12 p.d., note the dystrophic hair follicles and the melanin
clumps (blue arrowheads), and the lack of ND-GFP fluorescence in the
outer-root sheath in the mice treated with doxorubicin. The number of
ND-GFP-expressing blood vessels (red arrowheads) in the mice treated
with (a) doxorubicin was much less than (b) the control mice. The
hair-follicle stem cells in the bulge area were not affected by doxorubicin
(white arrowheads, white dashed areas). Bar¼ 100mm.
Figure 2. Immunohistochemical staining. CD31 was detected in frozen
sections with the anti-rat Ig horseradish peroxidase detection kit (BD
Pharmingen, San Diego, CA) following the instructions from the
manufacturer. The primary antibody was CD31 mAb (1:50) (CBL1337)
(Chemicon, Temecula, CA). Substrate-chromogen 3,30-diaminobenzidine
staining was used for antigen staining. The frozen sections were stained
with propidium iodide (Sigma-Aldrich Inc., St Louis, MO) (5 mg/ml in
phosphate-buffered saline). After this, the frozen sections were used for
immunohistochemical staining. Red arrows indicated the presence of CD31,
which colocalizes with ND-GFP fluorescence. Bar¼ 100mm.
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vessel density in the lower part of hair-follicle bulge area in
doxorubicin-treated mice was 0.56 (70.08) and in NaCl-
treated mice 1.16 (70.18). The data represent the mean
valuesþ SD (Po0.001) (Figure 6).
Frozen sections for TUNEL staining were made from the
skin from mice treated with doxorubicin. We could observe
apoptotic cells in sebaceous glands. However, we did not
observe apoptotic cells in the ND-GFP-expressing dermal
blood vessels of the mice treated with doxorubicin.
Furthermore, the ND-GFP-expressing blood vessel density
in the upper part of hair-follicle bulge in the mice treated with
doxorubicin was comparable to the control mice treated with
NaCl (Figure 6). Most importantly, the ND-GFP-expressing
blood vessel density in the lower part of hair-follicle bulge
was significantly shorter in the mice treated with doxorubicin
than in the control mice treated with NaCl (Figure 5). Thus,
it appears that doxorubicin does not cause apoptosis in
ND-GFP-expressing blood vessels but inhibits the growth of
the ND-GFP-expressing blood vessels in the lower part of
hair-follicle bulge.
DISCUSSION
Mecklenburg et al. (2000) showed that synchronized hair-
follicle cycling in adolescent C57BL/6 mice is associated with
substantial angiogenesis. Mecklenburg et al. (2000) also
observed that inhibiting angiogenesis with a fumagillin
derivative inhibits experimentally induced anagen develop-
ment in these mice. Yano et al. (2001) observed perifollicular
vascularization during the induced adult hair cycle and post-
natal hair development. No endothelial proliferation was
observed during catagen and telogen (Yano et al., 2001).
Our previous observation suggests that hair-follicle stem
cells can form blood vessels that form a dermal inter-
follicular microvasculature network (Li et al., 2003; Amoh
et al., 2004). In the present study, we visualized the formation
of the inter-follicular microvasculature network during hair-
follicle cycling using ND-GFP-expressing transgenic mice.
The length of ND-GFP-expressing blood vessels increased
during depilation-induced anagen development.
Doxorubicin induces disruption of the hair cycle and
subsequent alopecia in the ND-GFP model. We showed that
doxorubicin caused inhibition of blood vessel growth as well
as inhibition of the ND-GFP-expressing outer-root sheath
cells. Dystrophic hair follicles were observed in different hair
cycle stages. The fact that the hair follicle stem cells were
unaffected by doxorubicin may explain why hair grows back
after chemotherapy.
These results suggest that doxorubicin causes inhibition of
hair-follicle-associated angiogenesis and that this inhibition
may play a major role in chemotherapy-induced dystrophy
and alopecia. On the other hand, the hair-follicle-derived
blood vessels also vascularize tumors implanted in the skin,
and this process is also inhibited by doxorubicin (Amoh et al.,
2005a, c). This mouse model is useful for the study of the role
of angiogenesis in the hair-follicle cycle as well as in tumors
and the effect of chemotherapy drugs on these processes. The
model can be used to determine if specific agents, selectively
delivered to the hair follicle (Li and Hoffman, 1995), can
accelerate the effects of chemotherapy on hair-follicle
angiogenesis and associated dystrophy while still allowing
tumor angiogenesis to be inhibited.
MATERIALS AND METHODS
ND-GFP-transgenic mice
Transgenic mice carrying GFP under the control of the nestin
second-intron enhancer were used in this study (ND-GFP mice)
(Hoffman, 2000; Mecklenburg et al., 2000; Yano et al., 2001; Amoh
et al., 2004). ND-GFP-transgenic mice were originally obtained from
Dr G Enikolopov, Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY) (Mignone et al., 2004).
Visualization of nestin expression during the hair cycle
ND-GFP mice, with almost exclusively telogen hair follicles, were
anesthetized with tribromoethanol (intraperitoneal injection of
0.2 ml per 10 g of body weight of a 1.2% solution) (Amoh et al.,
2004). The mice were depilated with a hot mixture of rosin and
beeswax to induce anagen. Skin samples were excised from the
dorsal area under anesthesia before depilation (telogen) and at 48
hours, 72 hours, day-6 (middle anagen), day-12 (late anagen), day-
18 (catagen) and at day-30 (telogen). The skin samples were divided
into two parts, one for fluorescence microscopy and the other for
frozen sections. The samples for frozen sections were embedded in
tissue-freezing embedding medium and frozen at 801C overnight.
Frozen sections 10 mm thick were cut with a CM1850 cryostat
(Leica, Deerfield, IL) and were air-dried.
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Figure 6. Effect of doxorubicin on ND-GFP-expressing blood vessel density.
The ND-GFP-expressing blood vessel length in the lower part of hair-follicle
bulge was significantly shorter in the mice treated with doxorubicin than in
the control mice treated with NaCl. The ND-GFP-expressing blood vessel
length in the upper part of hair-follicle bulge in the mice treated with
doxorubicin was comparable to the control mice treated with NaCl. At least
five fields were examined for each section, derived from three different mice.
Treatment started 12 days p.d. The data represent the mean valuesþ SD
(*Po0.001). The results of inhibition of vessel length in the lower part of the
follicle by doxorubicin were significant compared to the control mice treated
with NaCl.
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Fluorescence microscopy
Fluorescence microscopy was carried out by using an Olympus IMT-
2 inverted microscope (Melville, NY) equipped with a mercury lamp
power supply (Amoh et al., 2004). The microscope had a GFP filter
set (Chroma Technology, Rockingham, VT).
Immunohistochemical staining
CD31 was detected in frozen sections with an anti-rat immuno-
globulin horseradish peroxidase detection kit (BD Pharmingen, San
Diego, CA) following instructions from the manufacturer. The
primary antibody used was CD31 mAb (1:50) (CBL1337) (Chemicon,
Temecula, CA). Substrate-chromogen 3,30-diaminobenzidine stain-
ing was used for antigen staining. The frozen sections were also
stained with propidium iodide (Sigma-Aldrich Inc., St Louis, MO)
(5mg/ml in phosphate-buffered saline).
Doxorubicin-induced alopecia
ND-GFP-transgenic mice, 6–8 weeks old, with almost exclusively
telogen hair follicles were used (Amoh et al., 2004). Mice were
anesthetized with tribromoethanol for all invasive procedures. The
mice were depilated by a hot mixture of rosin and beeswax. The
mice were given daily intraperitoneal injections of 5mg/g of
doxorubicin or 0.9% NaCl solution at days 0, 1, and 2 p.d. Samples
of dorsal skin were excised at days 7 and 12 and directly observed by
light and fluorescence microscopy with epidermis up and dermis
down. Skin samples for frozen sections were embedded in tissue-
freezing embedding medium and frozen at 801C overnight. Frozen
sections 10 mm thick were cut with a Leica CM1850 cryostat, and
were air-dried. Angiogenesis was quantified by measuring the length
of ND-GFP-expressing blood vessels. All fields at  40 or  100
magnification were measured. The total length of ND-GFP-expres-
sing nascent blood vessels was calculated. At least five fields were
examined for each section, derived from three mice per hair cycle
stage. Vessel density was calculated as the mean length of ND-GFP-
expressing blood vessels per square millimeter. Each experimental
group consisted of five mice.
TUNEL staining
Samples of dorsal skin were excised at days 6 and 12 and embedded
in tissue-freezing embedding medium and frozen at 801C over-
night. Frozen sections 10 mm thick were cut with a Leica CM1850
cryostat, and air-dried. TUNEL staining was performed with the
DermaTACSTM kit according to the manufacturer’s instructions (R&D
systems, Minneapolis, MN).
Statistical analysis
The experimental data are expressed as the mean7SD. Statistical
analysis was performed using the two-tailed Student’s t-test.
All animal studies were conducted in accordance with the
principles and procedures outlined in the NIH Guide for the Care
and Use of Animals under assurance number A3873-1. Animal
experiments were approved by the Institutional Animal Care and
Use Committee.
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